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A Review of Primary
Cardiomyopathy in the Cat
Thomas J. Fincel, DVM*
Brian L. Hill, DVM, MS**
INTRODUCTION
Primary cardiomyopathy in cats has been
recognized in the literature as a clinical entity
only since 1970. Prior to this, the recognition of
this disease had been in association with aortic
thromboembolism, an important complication
of cardiomyopathy. 1 Because the etiologies of
the several for~& 'of cardiomyopathy are un-
known, classification has been based on the na-
ture of the hemodynamic fault or the anatomi-
cal abnormality that is present. 2 The two most
basic and common forms are hypertrophic car-
diomyopathy and congestive cardiomyopathy.
Hypertrophic cardiomyopathy represents
severe left ventricular hypertrophy which
causes impaired ventricular distensibility and
compliance. Left atrial dilatation follows and
adds to the diastolic dysfunction which results
in left-sided congestive heart failure. Conges-
tive cardiomyopathy is characterized by poor
myocardial contractility, with dilatation of the
heart chambers and resultant failure of the
heart as a pump.3 A more recently described
form of idiopathic cardiomyopathy is restrictive
cardiomyopathy. This form is seen as a greatly
diminished ventricular compliance due to a
rigid, poorly distensible ventricular wall. 4
In addition to being a very important disease
in the cat, feline cardiomyopathy bears many
similarities to human cardiomyopathies, and
thereby provides a useful model for the study of
this disease in humans. 5
INCIDENCE
The increased incidence of idiopathic car-
diomyopathy in recent years is thought to be
due more to increased awareness than to in-
creased frequency of the disease in cats. Of the
*Dr. Fincel is a 1983 graduate of the College of Veteri-
nary Medicine at Iowa State University.
**Dr. Hill is an associate professor of Veterinary Clini-
cal Sciences at Iowa State University.
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two major forms of feline cardiomyopathy, the
hypertrophic form is more common. The cause
of hypertrophic cardiomyopathy in cats is un-
known, but evidence suggests a hereditary
component. The disease has been found in re-
lated cats, and in man a large number of cases
have a familial incidence. Cats' can be affected
at any age, but hypertrophic cardiomyopathy is
most common in middle-aged cats. Males are
more commonly affected than females.
Cats with congestive cardiomyopathy are
usually middle to older-aged. Like hy-
pertrophic cardiomyopathy, it occurs more
commonly in males than females. The third
and least common form, restrictive cardiomy-
opathy, is also usually found in middle-aged
cats.
There has been much speculation that the
various forms of cardiomyopathy may repre-
sent different stages of a single disease, but this
has yet to be proven.
CLINICAL DESCRIPTION
Hypertrophic Cardiomyopathy
As stated earlier, hypertrophic cardiomy-
opathy represents severe left ventricular hy-
pertrophy which causes impaired ventricular
distensibility and compliance. The hy-
pertrophy of the myocardium can be either
symmetric or asymmetric. In asymmetric hy-
pertrophy the septum is thicker than the left
ventricular free wall. In addtion to diminishing
the volume of the left ventricle, the outflow
tract may be obstructed by myocardium caus-
ing obstructive cardiomyopathy. The most
common form of left ventricular hypertrophy
in cats is symmetric. The septum, left ventricu-
lar free wall, and the papillary muscles are hy-
pertrophied resulting in a diminished volume
of the chamber.
As with the other forms of feline cardiomy-
opathy, the etiology is unknown but appears to
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involve a hereditary factor. The only breed
predilection identified at this time is the Per-
sian. 3 Some of the latest speculation raises the
possibility that hypertrophic cardiomyopathy
may be a disorder of developing embryonal en-
docrine tissue. 6 It is hypothesized that a genetic
fault results in disturbance of interaction be-
tween immature myocardial adrenergic recep-
tor sites and extra-cardiac catecholamines
during cardiac embryogenesis. This results in
cellular disarray and ventricular hypertrophy.
Other research is being directed at possible ab-
normal calcium metabolism, which may con-
tribute to the basic disease process. 4
The most common clinical signs of hy-
pertrophic cardiomyopathy in the cat are
dyspnea and aortic thromboen'lbolism. Other
less common presenting signs include lethargy,
anorexia, and sudden death. Auscultation is a
valuable tool in diagnosing this disease. Many
cats have a systolic murmur of mitral valvular
insufficiency and a third or fourth heart sound.
Macroscopic pathology shows hypertrophy
of the ventricular septum as well as the left
ventricular free wall and papillary muscles in
most cases. This results in a significant de-
crease in the size of the left ventricular cavity as
well as obstructing the outflow tract in many
cases. 7 Mitral valvular fibrosis/thickening and
hypertrophied papillary muscles result in a mi-
tral valvular insufficiency. Left atrial dilatation
is present, often to extreme degrees. Stress and
tachycardia appear to be important precipitat-
ing factors in producing the secondary effects,
pulmonary edema and acute dyspnea. A tachy-
cardia produced by the stress of exercise
shortens diastolic filling time. Cardiac output
falls, further limiting diastolic filling. The
snlaller lumen also contributes to decreased
ventricular filling and the resulting change in
end diastolic pressure. Cardiac output falls be-
cause the tachycardia is not sufficient to com-
pensate for the drop in stroke volume caused by
the poor filling. Pulmonary congestion and
edema with dyspnea result from the left-sided
heart faulure. 3 Another very important se-
quela, thromboembolism, occurs when blood
stagnates and clots in the very dilated left
atrium or in the apex of the left ventricle. After
these clots break free and enter the aorta, they
may lodge in several locations, the most com-
mon of which is the trifurcation of the descend-
ing aorta at the external iliac arteries. Other
less common areas of thromboembolism in-
clude the front legs, the kidneys, and the brain.
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Aortic thromboembolism itself is a cause of
stress and tachycardia because of the pain and
shock produced, and therefore, further com-
promises cardiac function.
Microscopic pathology in hypertrophic car-
diomyopathy is also very distinctive. The mus-
cle cells are enlarged and have large hyperchro-
matic nuclei. Muscle bundles show bizarre
disarrangement and are separated by an in-
creased amount of interstitial connective tissue.
There are often focal areas of the endocardium
that are replaced by active fibroplasia. Also, the
atrioventricular Purkinje fibers are frequently
interrupted by or mixed with many dense colla-·
gen fibers. 7
Electrocardiography is an important tool in
diagnosing hypertrophic cardiomyopathy.
However, a variety of abnormalities may be
seen, and this must be taken into account when
interpreting results. Prolongation and in-
creased amplitude of both the P wave and the
QRS interval in lead II are the most commonly
observed abnormalities. Most cats will also
show a left axis deviation, although normal axis
and right axis deviations have been recorded in
affected cats. Several types of atrioventricular
conduction disturbances are commonly seen,
as well as a left anterior fascicular branch block.
Rhythm disturbances include premature ven-
tricular contractions, atrial fibrillation, atrial
tachycardia, and ventricular tachycardia.
Radiology can also be very helpful in
diagnosing hypertrophic cardiomyopathy.
Gross cardiomegaly is present in most cases. In
the lateral view, the heart remains in its normal
oblique position within the thorax. There is
usually some tracheal elevation due to dilata-
tion of the left atrium. There is often radio-
graphic evidence of left ventricular enlarge-
ment, and there may be an increase in
sternal-cardiac contact area. The dorsoventral
projection is usually the n'lost helpful in visual-
izing the typical signs of hypertrophic car-
diomyopathy. The radiographic hallmark in
this view is the increased width of the cranial
portions of the cardiac silhouette with the apex
remaining narrow or becoming pointed, giving
the appearance of a characteristic "valentine-
shaped" heart. A prominence at the two o'clock
position is contributed by an enlarged left auri-
cular appendage, and the right prominence at
the nine to eleven o'cloCK position is due to the
"displaced" right ventricle. 2 A mild amount of
perihilar pulmonary edema is present in cases
with left heart failure. In more severe cases in-
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creased alveolar densities will be visualized
most extensively in the caudal lung lobes.
Angiography is even more helpful than sur-
vey radiographs in diagnosing hypertrophic
cardiomyopathy. Angiographic studies of the
left ventricle reveal severe left ventricular hy-
pertrophy with greatly reduced end diastolic
volume. Muscular hypertrophy around the bo-
dy of the ventricle usually appears to be greater
than that at the apex. Many angiocardiograms
also show evidence of radiolucent filling defects
in the left ventricle caused by hypertrophied
papillary muscles. Mitral insufficiency is
present along with a dilated left atrium. 7
Hemodynamic studies indicate two consis-
tent readings that may help diagnose the car-
diomyopathy. First, mean systolic pressures re-
main within normal limits. Second, the end
diastolic pressure is consistently increased
several times normal.
Laboratory findings with hypertrophic car-
diomyopathy are inconsistent. A neutrophilic
leukocytosis may occasionally be found. This
probably represents a stress reaction but must
be remembered when differentiating this dis-
ease from bacterial endocarditis. The muscle
enzyme levels are also occasionally elevated,
presumably from myocardial necrosis or skele-
tal muscle infarctions from arterial throm-
boembolism. Renal function tests may show
renal pathology if the renal artery is throm-
bosed. 2
Congestive Cardiomyopathy
Feline congestive cardiomyopathy is charac-
terized by dilated ventricles and atria with poor
myocardial contractility. The result of these
changes is the failure of the heart as a pump.
Congestive cardiomyopathy is considered a
primary myocardial disease of unknown cause;
however, several etiologies have been pro-
posed. Present thought is that congestive car-
diomyopathy is the result of myocardial dam-
age caused by a variety of myocardial insults.
Since the domestic cat is affected by many viral
diseases, the possible progression of viral
myocarditis to cardion'lyopathy presents the
most popular hypothesis at this time. Pi-
cornaviruses, herpesviruses, and reoviruses
have been isolated from affected cats, and a
latent or carrier state has been implicated for
feline herpesvirus. 7 This still remains largely
unsupported, and there have been few observa-
tions of a transition from myocarditis to con-
gestive cardiomyopathy. Viral myocarditis is a
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well-established entity in humans and is also
considered a possible cause of cardiomyopathy
in n'lan. There are a variety of alternative
etiologies that have been postulated with little
supporting evidence. One of these is an immu-
nologic disorder causing circulating anti-
myocardial antibodies and .defective suppressor
cell function of lymphocytes. Others include
endocrine abnormalities involving prostaglan-
din E 1, and effects of chemical toxins on the
myocardium.
The most common presenting clinical signs
seen with feline congestive cardiomyopathy in-
clude anorexia and lethargy. Other signs in-
clude dyspnea, shock, depression, dehydration,
hypothermia, bradycardia, and aortic throm-
boembolism. 3 Pleural effusion is a common re-
sult of the right-sided heart faulure, yet ascities
is rarely seen. Auscultation may reveal muffied
heart sounds due to pleural effusion. Systolic
murmurs of mitral and tricuspid insufficiency
as well as third heart sounds are also frequently
found if there is not excessive fluid in the
thorax.
Macroscopic pathology of congestive car-
diomyopathy shows generalized cardiomegaly
with ventricular and atrial dilatation. This re-
sults in a globular-shaped heart with thin, flab-
by ventricular walls; papillary muscles and tra-
beculae are flattened and atrophic. Also, areas
of endocardial fibrosis are seen as with hy-
pertrophic cardiomyopathy. Hydrothorax is of-
ten seen, along with pulmonary congestion and
edema, and hepatic congestion. Thromboem-
bolism is also frequently seen, again most com-
monly in the caudal abdominal aorta. 5
Microscopic examination reveals only minor
cardiac histopathologic alterations. There is
usually a mild hypertrophy of the muscle fibers
in the ventricular walls, as well as a mild, dif-
fuse myocardial interstitial fibrosis. Unlike the
hypertrophic form, myofibril disarray is not
present. 5
The most frequent electrocardiographic ab-
normalities seen with congestive cardiomy-
opathy include premature ventricular contrac-
tions and a tall, wide QRS complex in lead II.
Other abnormalities may be inconsistently ob-
served, but there usually is no significant axis
deviation. 7
Radiology can be helpful in identifying cats
with congestive cardiomyopathy; however, due
to a high degree of variability, radiographic
signs are not normally considered diagnostic.
Pleural effusion, a complication often present
Iowa State Veterinarian
in these cats, must be resolved with thoracocen-
tesis or diuretic therapy prior to radiography.
The radiographic change most commonly seen
is an enlarged, globular-shaped heart due to
dilatation of all chambers. Hepatomegaly is
another frequently seen sign of right heart
failure in addition to pulmonary edema. As
stated previously, ascites is rarely seen, unlike
right-sided heart failure in the dog.
Angiography is one of the most reliable
methods of diagnosing congestive cardiomy-
opathy if the patient is not debilitated to un-
dergo the study. There is often extreme ventric-
ular dilatation with increased end diastolic
volume. Atrioventricular valvular insufficiency
is also commonly seen together with dilated
atria. Another very distinctive change often ob-
served is a very prolonged circulation time. 3
Hemodynamic studies have shown two
changes that can be helpful in diagnosing con-
gestive cardiomyopathy. First, the left ventricu-
lar systolic pressure is commonly low or at the
low end of normal. Second, as in hypertrophic
cardiomyopathy, the left ventricular end diasto-
lic pressure is consistently several times higher
than normal.?
Laboratory findings are inconsistent and
similar to those found with the hypertrophic
form of feline cardiomyopathy. Possible dif-
ferences that may be observed with the conges-
tive form are an increase in the levels of the
liver enzymes due to hepatic congestion, and a
pre-renal azotemia.
Restrictive Cardiomyopathy
Restrictive cardiomyopathy is the most re-
cently described form of the feline cardiomy-
opathies. It is also the most uncommon. Two
basic pathologic forms of restrictive cardiomy-
opathy have been described. The first is
characterized by severe endocardial fibrosis.
The second form is less common and is asso-
ciated with increased numbers of abnormal
moderator bands in the left ventricle. At the
present tin1e, the etiologies of both of these are
unknown.
Restrictive cardiomyopathy due to endocar-
dial fibrosis shows many of the same signs as
the other cardiomyopathies. It occurs most fre-
quently in middle-aged male cats. The most
common presenting signs are dyspnea, anorex-
ia, and thromboembolism. Electrocardio-
graphy often reveals conduction and rhythm
disturbances including premature ventricular
contractions and atrial fibrillation. Radiology
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frequently shows left atrial enlargement and
sometimes shows the presence of pleural fluid.
Angiography is again the best way to show the
changes of endocardial fibrosis in the living cat.
The most frequently observed signs are apical
dilatation of the left ventricle and irregular fill-
ing defects. A-V valvular insufficiency and
severe left atrial enlargement are also common.
Gross pathology of the heart reveals severe en-
docardial thickening, especially of the left ven-
tricular inflow and outflow tracts, papillary
muscles, and chordae tendinae. Left atrial
enlargement is usually evident. Histologically,
severe endocardial fibrosis is seen. 4
Restrictive cardiomyopathy due to abnormal
moderator bands is also most often found in
middle-aged male cats. Again, the most com-
mon clinical signs include dyspnea, lethargy,
anorexia, and thromboembolism. The patholo-
gical change in this form of cardiomyopathy is
an abnormal network of left ventricular moder-
ator bands and an associated cardiac decom-
pensation. The moderator bands are increased
in number and size and are seen bridging the
left ventricular free wall and septum and entan-
gling the papillary muscles. Electrocardio-
graphic abnormalities show intraventricular
conduction defects, especially right bundle
branch block, and atrioventricular blocks and
bradyarrythmias. Radiology may reveal gener-
alized cardiomegaly, hydrothorax, and
pulmonary edema. Angiography shows irregu-
larly shaped or indented left ventricles and a
dilated left atrium. 9
Aortic Thromboembolism
Systemic arterial embolism occurs in ap-
proximately 50 % of all cats with symptomatic
cardiomyopathy, making this the most com-
mon complication accompanying this disease.
Aortic thromboembolism was well-described
many years before its relationship with car-
diomyopathy was known. This recognition
comes from the relatively dramatic clinical
signs that occur when a major artery is oc-
cluded.
It is generally thought that most thrombi ori-
ginate in the left atrium, aorta, and apex of the
left ventricle. Most are considered to be due to
mural or arterial lesions. The most common
site of acute major arterial thromboembolism is
the caudal aorta at the trifurcation of the ex-
ternal iliac arteries. Usually both rear legs are
affected, but the lesion can be unilateral. Other
common areas of thromboembolism include
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the brachial arteries, the renal arteries, and the
mesenteric arteries.
Clinical signs on presentation will be deter-
mined by the area of ischemia involved. Hind
leg signs range from pain and ataxia soon after
the embolism, progressing to complete flaccid
paralysis. The affected limbs will be cyanotic,
cool, and painful with no fenl0ral pulse. The
gastrocnemius muscle is often contracted and
the local neural reflexes are lost. Also, a toenail
may be clipped short and it will not bleed nor-
mally. Renal function tests may show severe
azotemia if one of both renal arteries are oc-
cluded. Abdominal pain may also result from
renal or mesenteric artery embolization.
The severity of signs will depend on how
quickly adequate collateral circulation can be
established. Simple mechanical occlusion will
not prevent the development of adequate colla-
terail circulation. However, there is a release of
vasoactive substances from the thrombus, most
importantly serotonin, which causes vasocon-
striction of collateral vessels. Therefore, effec-
tive collateral circulation only occasionally de-
velops in clinical cases of aortic
thromboembolism. 1 Selective arterial or nonse-
lective venous angiography can be used to de-
termine the location and extent of a thrombus
as well as to visualize any developing collateral
circulation.
TREATMENT
In general, therapy for a cat presented with
the common signs of cardiomyopathy (dyspnea
or thromboembolism) is directed toward stabi-
lizing the patient until their complete status can
be evaluated. Phenothiazine tranquilizers are
recommended for two reasons. First, tranquil-
izers will sedate the animal and reduce stress,
which is an important precipitating factor in
the cardiac decompensation. Second, these
drugs cause vasodilation which will help open
collateral vessels in the case of thrornboembol-
ism. Also, phenothiazines are hypotensive
drugs, which must be remembered if the ani-
mal is in circulatory failure.
Oxygen therapy should be administered if
the animal is hypoxic, and 35 % alcohol can be
nebulized if pulmonary edema is severe. Furo-
semide should also be started in cases with
dyspnea from pulmonary edema or pleural
fluid. An initial dose of 1 to 2 mg/lb is given
intravenously for fast effect. Thoracocentesis
can also be done for cases with significant
pleural effusion. Aminophylline may be indi-
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cated at a dosage of 5 mg/lb for its bronchodila-
tor effects if dyspnea is severe. Rapid digitaliza-
tion may rarely be indicated in cases with
severe heart failure, but cats tolerate digitalis
glycosides very poorly and toxicity reactions
are common.
Arterial Thromboembolism
Once the patient is stabilized, the most im-
portant presenting problem is bilateral rear leg
paresis/paralysis due to aortic thromboembol-
ism. The neurologic and muscular status of the
area should be evaluated to determine the
severity of the insult and to evaluate the prog-
ress of treatment. A phenothiazine tranquilizer
like acetylpromazine maleate should be given
for its sedative effects. Its sympatholytic effect
also helps establish collateral circulation by
causing vasodilation.
Anticoagulants are also indicated to prevent
further thrombosis. Arterial thrombi are initi-
ated by platelet aggregation with secondary fi-
brin deposition, whereas venous thrombi con-
sist primarily of fibrin clots. Therefore, platelet
anti-aggregates are indicated, usually aspirin.
A dosage of buffered aspirin of 1f4 of a five grain
tablet every day can be given to the average-
sized cat and is an effective platelet anti-aggre-
gate. Aspirin works by inhibiting the pro-
staglandin thrombroxane A2 , which is the
factor that is thought to promote collateral inhi-
bition and platelet aggregation after aortic
thrombosis in the cat. lO Heparin may also be
used for its anti-clotting effects at a dosage of 50
IV intravenously and repeated every eight
hours subcutaneously.
Surgical embolectomy can be attempted but
is not widely recommended. These cats are of-
ten very poor anesthetic risks. Also, the success
rate of the surgery is poor due to the associated
vasoconstriction and recurrence of the clot. If
embolectomy is to be attempted, the patient
should be stable and the surgery must be per-
formed as soon as possible to increase the
chances of success. The aorta is opened over
the area of the thrombus via a ventral midline
incision. Indications for embolectomy include
thrombosis proximal to the renal arteries, com-
plete neurologic dysfunction of the hindlegs, a
worsening condition with medical treatment,
and thrombosis in a cat with stable cardiovas-
cular function.
Thrombolytic agents like urokinase or strep-
tokinase may be of benefit, but have not been
clinically evaluated; also, prostacyclin has been
advocated.
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Hypertrophic Cardiomyopathy
Once the diagnosis has been made of the
type of cardiomyopathy an individual patient
has, treatment can be initiated to try to correct
the underlying cardiac problems. In hy-
pertrophic cardiomyopathy the pathogenesis is
a stress-related release of endogenous catechol-
amines which causes stimulation of beta-
adrenergic receptors in the heart. This causes
an increase in heart rate and myocardial oxy-
gen consumption and a decrease in diastolic
filling time. Propranolol is a beta-adrenergic
antagonist that is commonly used to counteract
the increased level of catecholanlines. Pro-
pranolol should be used only after pulmonary
edema and other signs of heart failure have
been resolved. By using this drug, it is hoped
that ventricular filling will be improved, oxy-
gen requirements will be reduced, and cardiac
automaticity will be decreased. In addition,
propranolol inhibits platelet aggregation which
may help in the prevention of thrombus forma-
tion. Propranolol should not be used in patients
with aortic thromboembolism due to its vaso-
constrictive effects. It is used at a dosage of 2.5
to 5.0 mg, two or three times a day in an
average size cat. The main benefit of proprano-
lol is as a preventative of heart failure in hy-
pertrophic cardiomyopathy, and it is very im-
portant that signs of heart failure not be present
before or after propranolol is used. A beta! an-
tagonist may also be used for its more selective
effects.
Furosemide is also indicated for long-term
treatment of hypertrophic cardiomyopathy. It
is given to eliminate excess fluid from the pa-
tient and to cause a slightly negative sodium
balance. The dosage should be adjusted to the
individual's response and be kept to the small-
est effective dose on an intermittent schedule. 4
Congestive Cardiomyopathy
Cats that are diagnosed as having congestive
cardiomyopathy usually are presented with
pulmonary edema and pleural effusion. As
stated earlier, diuretics and thoracocentesis are
usually indicated. Shock and dehydration are
also common findings, so fluids like 5 % dex-
trose may be administered intravenously. The
major treatment for the heart failure is a car-
diac glycoside for its positive inotropic and neg-
ative chronotropic effects. Digoxin is tolerated
very poorly in the cat, so dosages must be
monitored very closely. Toxicity is character-
ized by vonliting, diarrhea, and anorexia. Cats
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in very serious condition nlay be rapidly digita-
lized intravenously with a dose of 0.01 mg/lb of
body weight divided into four doses given over
four hours. Slow digitalization is preferred and
done at a dose of 0.003 to 0.005 mg/lb of body
weight per day divided into two doses. 2 Vasodi-
lators such as nitroglycerine ointment may be
of benefit in the acute treatment of some cats
with heart failure. The prognosis for cats with
congestive cardiomyopathy is grave, and they
commonly die within the first day or two.
Long-term treatment for those that survive the
initial episode includes digoxin and furosemide
therapy with restriction of exercise and sodium.
Some recent work has also shown that a be-
ta-blocker like propranolol may be of help after
the patient has been digitalized and is out of
heart failure. It will reduce a high heart rate to
allow better diastolic filling and more efficient
use of oxygen by the myocardium. Other re-
cent work indicates that an oral vasodilator
may be indicated for long-term treatment. It is
postulated that the beneficial effects are from
the decreased work of the heart due to periph-
eral vasodilatation.
Restrictive Cardiomyopathy
There has not been sufficient research on the
treatment of the two forms of restrictive car-
diomyopathy to suggest the best treatment reg-
imen. In many cases progression of the disease
is so advanced by the time of presentation that
therapy may be of little benefit. Therapy is
based on the presenting signs with digoxin and
furosemide being two of the most commonly
used drugs.
CONCLUSION
Substantial advances in our understanding
of feline cardiomyopathy have been gained
over the past 15 years. However, these begin-
nings have dealt largely with the clinical and
pathologic aspects of this major problem in vet-
erinary cardiology. Much has yet to be learned
about the etiologies and relationships of the dif-
ferent fornls of feline cardiomyopathy. There is
also much work to be done in finding the best
treatments for the wide range of pathological
disturbances this disease presents. In addition,
it appears that feline cardiomyopathy closely
resembles and will be an important contribu-
tion to the understanding of human cardiomy-
opathy. One thing is certain, the understanding
of the many aspects of feline cardiomyopathy
will continue to be a challenge to researchers
and clinicians alike.
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AVMA Sponsors Meeting on FDA's
Revised Drug-Use Policy
A recently announced change in the Food
and Drug Administration (FDA) policy on the
use of drugs in food-producing animals re-
sulted in a conference called by the AVMA at
its Schaumburg, Illinois, headquarters on Sep-
tember 27, 1983.
The meeting was organized in response to an
outcry of concern from veterinarians and pro-
ducers that a new policy announced by the
FD.Ns Bureau of Veterinary Medicine last July
would impose excessive restrictions on extra-
label use of food-animal drugs. Under the
FD.Ns revised policy, a finding of illegal drug
residues will no longer be the only reason for
initiating punitive action. The revised policy
states that use of a drug in food animals for a
purpose or in a dosage not specified on the
product's label directions will also be justifica-
tion for punitive action.
The changes recommended at the September
conference would assure that the FDA will not
interfere when, in the veterinarian's profes-
sional judgment, there is a need to treat a food
animal with a drug or a dosage not specifically
approved by the FDA for an existing disease
condition.
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It is expected that the recommended changes
will be reviewed for possible endorsement by
the AVMA and other national groups, and
, hopefully acted upon by FDA authorities.
If the FDA fails to amend its revised policy, it
is possible that veterinarians will be practicing
under a regulatory cloud of impropriety when
they decide to use a drug for purposes not ex-
actly stated on the label.
However, if the recommended changes are
adopted, FDA authorities would continue to
take action against veterinarians in cases where
drugs are illegally used and/or distributed for
purposes not stated on the product label, and
in the absence of a veterinarian-client-patient
relationship. FDA authorities would respect
the veterinarian's professional prerogatives
when a veterinarian-client-patient relationship
has been established so that the veterinarian is
familiar with the owner, the animal, the prem-
ises, and knows the management conditions.
FDA authorities, however, will still hold the
veterinarian and the client responsible for any
drug residues in food products that may occur
following treatment regimens that do not fol-
low label directions.
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